Chloroquine for COVID-19: rationale, facts, hopes
نویسندگان
چکیده
منابع مشابه
Prophylactic Effect of Chloroquine and Hydroxy chloroquine in COVID-19 Treatment
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named ‘coronavirus disease 2019’ (COVID-19), which threatens human health and public safety.Hydroxychloroquine (HCQ) is an anti-malaria drug; its antiviral properties are controversial,and some in vitr...
متن کاملCoronavirus Disease 2019 (Covid-19) in Middle East: Data, Facts and Doubts
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a newly discovered coronavirus. A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO Country Office in China on 31 December 2019. The outbreak was declared a Public Health Emergency of International Concern on 30 January 2020. On 11 February 2020, WHO announced a name for the new coronavirus di...
متن کاملGenetic markers of osteoarticular disorders: facts and hopes
Osteoarthritis and osteoporosis are the two most common age-related chronic disorders of articular joints and skeleton, representing a major public health problem in most developed countries. Apart from being influenced by environmental factors, both disorders have a strong genetic component, and there is now considerable evidence from large population studies that these two disorders are inver...
متن کاملMedical strategies for Disease Covid-19
Following the outbreak of Covid-19, many related studies were published rapidly around the world. In this study, we examined published or in-publication studies over the strategies to deal with Covid-19. To this end, 16 published scientific papers were investigated using content analysis and meta-analysis. As a result, 16 medical strategies and 3 macro-management strategies were extracted. Fina...
متن کاملChemoprophylatic. Ayurvedic, Homeopathic and Unani approaches for COVID-19 prophylaxis
There are no specific therapies approved by the U.S. FDA for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 COVID-19. Several agents are under clinical trial and the use of pharmacological agents are based on in vitro activity against SARS-CoV-2 or related viruses. While the efficacy of drug therapy is yet to be established, we need ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Critical Care
سال: 2020
ISSN: 1364-8535
DOI: 10.1186/s13054-020-02932-4